Positive Press Coverage Somewhat Unlikely to Affect Blackrock Health Sciences Trust (BME) Share Price

Media stories about Blackrock Health Sciences Trust (NYSE:BME) have trended positive recently, according to Accern. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.47 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.4573692829231 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of Blackrock Health Sciences Trust (NYSE:BME) opened at $36.01 on Friday. Blackrock Health Sciences Trust has a one year low of $32.56 and a one year high of $38.00.

The company also recently declared a monthly dividend, which was paid on Wednesday, January 31st. Stockholders of record on Tuesday, January 16th were paid a $0.20 dividend. The ex-dividend date was Friday, January 12th. This represents a $2.40 annualized dividend and a dividend yield of 6.66%.

TRADEMARK VIOLATION NOTICE: “Positive Press Coverage Somewhat Unlikely to Affect Blackrock Health Sciences Trust (BME) Share Price” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/02/positive-press-coverage-somewhat-unlikely-to-affect-blackrock-health-sciences-trust-bme-share-price.html.

About Blackrock Health Sciences Trust

BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

Insider Buying and Selling by Quarter for Blackrock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply